Literature DB >> 8693973

Improved detection of enhancing and nonenhancing lesions of multiple sclerosis with magnetization transfer.

R C Mehta1, G B Pike, D R Enzmann.   

Abstract

PURPOSE: To determine whether magnetization transfer imaging can improve visibility of contrast enhancement of multiple sclerosis plaques.
METHODS: Fifty-nine enhancing and 63 nonenhancing lesions in 10 patients with multiple sclerosis were evaluated to calculate contrast-to-noise ratios on conventional T1-weighted and T1-weighted magnetization transfer images. The signal intensity of the lesion and the background (white matter) were measured on precontrast T1-weighted and T1-weighted magnetization transfer images (800/20/1 [repetition time/echo time/excitations]) and on postcontrast T1-weighted and T1-weighted magnetization transfer images. Mean contrast-to-noise ratios was calculated for all lesions.
RESULTS: The contrast-to-noise ratio was significantly higher for enhancing and nonenhancing lesions on T1-weighted magnetization transfer images than on conventional T1-weighted images. For enhancing lesions, the contrast-to-noise ratio was significantly higher on postcontrast T1-weighted magnetization transfer images, 32 +/- 2 compared with 21 +/- 2 on conventional T1-weighted images. Fifty of the 59 enhancing lesions were seen on both the T1-weighted and the T1-weighted magnetization transfer images. Nine enhancing lesions were seen only on the postcontrast T1-weighted magnetization transfer images. In addition, of 63 nonenhancing lesions seen on proton-density, T2-weighted, and T1-weighted magnetization transfer images, 16 were not seen on the conventional T1-weighted images. Seven of the 63 nonenhancing lesions and 7 of the 59 enhancing lesions had high signal intensity on the precontrast T1-weighted magnetization transfer images suggestive of lipid signal, a finding not seen on the conventional precontrast T1-weighted images.
CONCLUSION: Magnetization transfer improves the visibility of enhancing multiple sclerosis lesions, because they have a higher contrast-to-noise ratio than conventional postcontrast T1-weighted images. High signal intensity on both nonenhancing and enhancing lesions noted only on precontrast T1-weighted magnetization transfer suggests a lipid signal was unmasked. If magnetization transfer is used in multiple sclerosis patients, a precontrast magnetization transfer image is necessary.

Entities:  

Mesh:

Year:  1995        PMID: 8693973      PMCID: PMC8338214     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  6 in total

1.  Contrast enhancement of intracranial lesions: conventional T1-weighted spin-echo versus fast spin-echo MR imaging techniques.

Authors:  T Sugahara; Y Korogi; Y Ge; Y Shigematsu; L Liang; K Yoshizumi; M Kitajima; M Takahashi
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

2.  Brain MR post-gadolinium contrast in multiple sclerosis: the role of magnetization transfer and image subtraction in detecting more enhancing lesions.

Authors:  M M Gavra; C Voumvourakis; A D Gouliamos; C Sfagos; L J Vlahos
Journal:  Neuroradiology       Date:  2004-02-19       Impact factor: 2.804

Review 3.  Magnetization transfer imaging of multiple sclerosis.

Authors:  G B Pike
Journal:  Ital J Neurol Sci       Date:  1997-12

Review 4.  Magnetic resonance in monitoring the natural history of multiple sclerosis and the effects of treatment.

Authors:  M Filippi; M Rovaris; G Comi
Journal:  Ital J Neurol Sci       Date:  1996-12

5.  Triple-dose contrast/magnetization transfer suppressed imaging of 'non-enhancing' brain gliomas.

Authors:  Bradley J Erickson; Norbert G Campeau; Shawn A Schreiner; Jan C Buckner; Brian P O'Neill; Judith R O'Fallon
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

6.  Importance of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of the Treatment Efficacy in Multiple Sclerosis Patients with Acute Attacks.

Authors:  Tuna Sahin; Zülküf Bozgeyik; Mehmet Sait Menzilcioglu; Serdal Citil; Mehmet Fatih Erbay
Journal:  Pol J Radiol       Date:  2015-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.